Header Logo

Shiyoung Roh

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Telemedicine
6
2024
336
0.880
 Why?
Glaucoma, Open-Angle
6
2023
38
0.860
 Why?
Glaucoma
4
2023
46
0.770
 Why?
Intraocular Pressure
7
2023
60
0.620
 Why?
Diabetic Retinopathy
3
2024
45
0.620
 Why?
Macular Degeneration
2
2024
179
0.340
 Why?
Hyphema
1
2008
3
0.310
 Why?
Product Packaging
1
2008
6
0.310
 Why?
Eye Injuries
1
2008
14
0.300
 Why?
Diabetes Mellitus
2
2023
538
0.280
 Why?
Wounds, Nonpenetrating
1
2008
102
0.280
 Why?
Patient Portals
1
2024
47
0.230
 Why?
Visual Acuity
3
2024
118
0.220
 Why?
Geographic Atrophy
1
2024
20
0.220
 Why?
Wet Macular Degeneration
1
2023
26
0.210
 Why?
Ophthalmology
1
2022
23
0.190
 Why?
Smartphone
1
2021
64
0.170
 Why?
Dark Adaptation
1
2019
8
0.160
 Why?
Follow-Up Studies
4
2024
2341
0.120
 Why?
Humans
15
2024
59817
0.110
 Why?
Pandemics
3
2023
623
0.110
 Why?
Intravitreal Injections
2
2024
49
0.110
 Why?
Optic Nerve
2
2023
28
0.100
 Why?
Patient Compliance
2
2024
372
0.090
 Why?
Anterior Chamber
1
2008
5
0.080
 Why?
Antihypertensive Agents
2
2007
173
0.070
 Why?
Phacoemulsification
1
2007
7
0.070
 Why?
Trabeculectomy
1
2007
9
0.070
 Why?
Cataract
1
2007
54
0.070
 Why?
Prostaglandins F, Synthetic
1
2006
1
0.070
 Why?
Amides
1
2006
51
0.060
 Why?
Cross-Sectional Studies
2
2021
2489
0.060
 Why?
Lipids
1
2006
307
0.060
 Why?
Telephone
1
2023
121
0.050
 Why?
Appointments and Schedules
1
2023
54
0.050
 Why?
Ranibizumab
1
2021
20
0.050
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2021
33
0.050
 Why?
Nerve Fibers
1
2021
29
0.050
 Why?
Retinal Ganglion Cells
1
2021
27
0.050
 Why?
Female
5
2024
31100
0.050
 Why?
Bevacizumab
1
2021
57
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2021
14
0.050
 Why?
Angiogenesis Inhibitors
1
2021
78
0.040
 Why?
Aged
4
2024
13463
0.040
 Why?
Photography
1
2021
43
0.040
 Why?
Retina
1
2021
119
0.040
 Why?
Recombinant Fusion Proteins
1
2021
502
0.040
 Why?
Retrospective Studies
2
2021
6040
0.040
 Why?
Disease Progression
1
2023
1052
0.040
 Why?
Visual Fields
1
2019
43
0.040
 Why?
Tomography, Optical Coherence
1
2021
207
0.040
 Why?
Referral and Consultation
1
2021
410
0.040
 Why?
Patient Satisfaction
1
2021
413
0.040
 Why?
Middle Aged
3
2024
16402
0.040
 Why?
Adolescent
1
2008
5939
0.040
 Why?
Prospective Studies
2
2019
3110
0.030
 Why?
Male
4
2024
27771
0.030
 Why?
Pilot Projects
1
2019
927
0.030
 Why?
Reproducibility of Results
1
2019
1559
0.030
 Why?
Aged, 80 and over
2
2019
5149
0.030
 Why?
Risk Factors
1
2022
5040
0.020
 Why?
Surveys and Questionnaires
1
2019
2600
0.020
 Why?
Tonometry, Ocular
1
2007
15
0.020
 Why?
Mitomycin
1
2007
23
0.020
 Why?
Lens Implantation, Intraocular
1
2007
7
0.020
 Why?
Bimatoprost
1
2006
1
0.020
 Why?
Cloprostenol
1
2006
1
0.020
 Why?
Ophthalmic Solutions
1
2006
12
0.020
 Why?
Double-Blind Method
1
2006
679
0.010
 Why?
Circadian Rhythm
1
2006
371
0.010
 Why?
Adult
1
2019
15882
0.010
 Why?
Roh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_